APHON Chemotherapy Overview
2025/2026 Exam Questions and
1
Corresponding Answers with Surety of
100% Pass Mark
Pre-clinical Studies - 🧠 ANSWER ✔✔purpose is to determine safe starting
dose for humans
Folic Acid - 🧠 ANSWER ✔✔Positive effect on kids w/ lymphoblastic
leukemia
Clinical trials - 🧠 ANSWER ✔✔comparing 2+ therapeutic tx in ctl setting to
evaluate effect of intervention of specific disease/s
Clinical Trial phase 1 - 🧠 ANSWER ✔✔how much can you handle before
breakdown?
determine max tolerated dose of drug or drug combo.
ID dose-limiting toxicities: highest dose for which incidence of dose limiting
toxicities is <33%
COPYRIGHT©PROFFKERRYMARTIN 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
PRIVACY STATEMENT. ALL RIGHTS RESERVED
, Clinical Trial Phase 1 Patient - 🧠 ANSWER ✔✔advanced disease, good
organ function, resistant to standard therapies
2
Clinical Trial phase 2 - 🧠 ANSWER ✔✔determines efficacy of new agent in
tx of specific cancer types and validate toxicity & dosage data. info r/t drug
administration, acute toxicity, & supporting care
Clinical Trial phase 2 Patient - 🧠 ANSWER ✔✔pt who show little to no
response to prior tx usually selected w/ normal organ function, measurable
tumor size, reasonable life expectancy & functional status.
Includes pt who have not been treated w/ investigational drug
Clinical Trial Phase 3 - 🧠 ANSWER ✔✔determine value of agent r/t existing
tx. Measure response, toxicity, survival & QOL
Clinical trial Phase 3 Patient - 🧠 ANSWER ✔✔large number of newly dx
who receive tx and observed over long period of time
Clinical Trial Phase 4 - 🧠 ANSWER ✔✔Occurs after agent is available in
commercial market. Efforts to decrease AE, toxicity w/ acceptable cure
rate. Focuses more on long term safety
COPYRIGHT©PROFFKERRYMARTIN 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
PRIVACY STATEMENT. ALL RIGHTS RESERVED
2025/2026 Exam Questions and
1
Corresponding Answers with Surety of
100% Pass Mark
Pre-clinical Studies - 🧠 ANSWER ✔✔purpose is to determine safe starting
dose for humans
Folic Acid - 🧠 ANSWER ✔✔Positive effect on kids w/ lymphoblastic
leukemia
Clinical trials - 🧠 ANSWER ✔✔comparing 2+ therapeutic tx in ctl setting to
evaluate effect of intervention of specific disease/s
Clinical Trial phase 1 - 🧠 ANSWER ✔✔how much can you handle before
breakdown?
determine max tolerated dose of drug or drug combo.
ID dose-limiting toxicities: highest dose for which incidence of dose limiting
toxicities is <33%
COPYRIGHT©PROFFKERRYMARTIN 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
PRIVACY STATEMENT. ALL RIGHTS RESERVED
, Clinical Trial Phase 1 Patient - 🧠 ANSWER ✔✔advanced disease, good
organ function, resistant to standard therapies
2
Clinical Trial phase 2 - 🧠 ANSWER ✔✔determines efficacy of new agent in
tx of specific cancer types and validate toxicity & dosage data. info r/t drug
administration, acute toxicity, & supporting care
Clinical Trial phase 2 Patient - 🧠 ANSWER ✔✔pt who show little to no
response to prior tx usually selected w/ normal organ function, measurable
tumor size, reasonable life expectancy & functional status.
Includes pt who have not been treated w/ investigational drug
Clinical Trial Phase 3 - 🧠 ANSWER ✔✔determine value of agent r/t existing
tx. Measure response, toxicity, survival & QOL
Clinical trial Phase 3 Patient - 🧠 ANSWER ✔✔large number of newly dx
who receive tx and observed over long period of time
Clinical Trial Phase 4 - 🧠 ANSWER ✔✔Occurs after agent is available in
commercial market. Efforts to decrease AE, toxicity w/ acceptable cure
rate. Focuses more on long term safety
COPYRIGHT©PROFFKERRYMARTIN 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
PRIVACY STATEMENT. ALL RIGHTS RESERVED
